S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology (2014/12/17)|
|Halozyme Therapeutics To Host Analyst And Investor Meeting (2014/12/30)|
|Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer (2015/1/5)|
|Halozyme Therapeutics To Present At The 25th Annual Oppenheimer Healthcare Conference (2014/12/3)|
|Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference (2015/1/6)|
|Halozyme Therapeutics Provides An Update On Anticipated Milestones For 2015 At The 33rd Annual J. P. Morgan Healthcare Conference (2015/1/12)|
|Philips and Indica Labs Team to Accelerate Cancer Research through Advanced Image Analysis (2015/1/15)|
|JAKKS Pacific Secures Worldwide Agreement to Produce Large Scale Figures and Costumes Based on Microsoft Studio’s Iconic Halo Property (2015/1/26)|
|Halozyme Provides Agenda Highlights For Analyst And Investor Meeting (2015/1/7)|
|Halozyme Announces Preclinical Study Results Of PEGPH20 Published In Molecular Cancer Therapeutics (2015/2/17)|
Click above to view more mutual fund data and stats for halo - Halozyme Therapeutics Inc.